Literature DB >> 26268987

Soya products and serum lipids: a meta-analysis of randomised controlled trials.

Oluwabunmi A Tokede1, Temilola A Onabanjo2, Alfa Yansane3, J Michael Gaziano1, Luc Djoussé1.   

Abstract

Soya proteins and isoflavones have been reported to exert beneficial effects on the serum lipid profile. More recently, this claim is being challenged. The objective of this study was to comprehensively examine the effects of soya consumption on the lipid profile using published trials. A detailed literature search was conducted via MEDLINE (from 2004 through February 2014), CENTRAL (The Cochrane Controlled Clinical Trials Register) and ClinicalTrials.gov for randomised controlled trials assessing the effects of soya on the lipid profile. The primary effect measure was the difference in means of the final measurements between the intervention and control groups. In all, thirty-five studies (fifty comparisons) were included in our analyses. Treatment duration ranged from 4 weeks to 1 year. Intake of soya products resulted in a significant reduction in serum LDL-cholesterol concentration, -4.83 (95% CI -7.34, -2.31) mg/dl, TAG, -4.92 (95% CI -7.79, -2.04) mg/dl, and total cholesterol (TC) concentrations, -5.33 (95% CI -8.35, -2.30) mg/dl. There was also a significant increase in serum HDL-cholesterol concentration, 1.40 (95% CI 0.58, 2.23) mg/dl. The I² statistic ranged from 92 to 99%, indicating significant heterogeneity. LDL reductions were more marked in hypercholesterolaemic patients, -7.47 (95% CI -11.79, -3.16) mg/dl, than in healthy subjects, -2.96 (95% CI -5.28, -0.65) mg/dl. LDL reduction was stronger when whole soya products (soya milk, soyabeans and nuts) were used as the test regimen, -11.06 (95% CI -15.74, -6.37) mg/dl, as opposed to when 'processed' soya extracts, -3.17 (95% CI -5.75, -0.58) mg/dl, were used. These data are consistent with the beneficial effects of soya proteins on serum LDL, HDL, TAG and TC concentrations. The effect was stronger in hypercholesterolaemic subjects. Whole soya foods appeared to be more beneficial than soya supplementation, whereas isoflavone supplementation had no effects on the lipid profile.

Entities:  

Keywords:  Heart disease; Hypercholesterolaemia; Lipids; Nutrition; Prevention; TC total cholesterol

Mesh:

Substances:

Year:  2015        PMID: 26268987     DOI: 10.1017/S0007114515002603

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  35 in total

1.  Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Authors:  Arrigo F G Cicero; Alessandro Colletti; Gani Bajraktari; Olivier Descamps; Dragan M Djuric; Marat Ezhov; Zlatko Fras; Niki Katsiki; Michel Langlois; Gustavs Latkovskis; Demosthenes B Panagiotakos; Gyorgy Paragh; Dimitri P Mikhailidis; Olena Mitchenko; Bernhard Paulweber; Daniel Pella; Christos Pitsavos; Željko Reiner; Kausik K Ray; Manfredi Rizzo; Amirhossein Sahebkar; Maria-Corina Serban; Laurence S Sperling; Peter P Toth; Dragos Vinereanu; Michal Vrablík; Nathan D Wong; Maciej Banach
Journal:  Arch Med Sci       Date:  2017-08-04       Impact factor: 3.318

2.  Soy consumption and incidence of gestational diabetes mellitus: the Japan Environment and Children's Study.

Authors:  Jia-Yi Dong; Takashi Kimura; Satoyo Ikehara; Meishan Cui; Yoko Kawanishi; Tadashi Kimura; Kimiko Ueda; Hiroyasu Iso
Journal:  Eur J Nutr       Date:  2020-06-06       Impact factor: 5.614

Review 3.  Optimizing Non-Pharmacologic Management of Hypertriglyceridemia.

Authors:  Alexandra Byrne; Sunal Makadia; Aimee Sutherland; Michael Miller
Journal:  Arch Med Res       Date:  2017-12-06       Impact factor: 2.235

Review 4.  Soy-based renoprotection.

Authors:  Nancy J McGraw; Elaine S Krul; Elizabeth Grunz-Borgmann; Alan R Parrish
Journal:  World J Nephrol       Date:  2016-05-06

Review 5.  Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk.

Authors:  Vanessa Bianconi; Massimo Raffaele Mannarino; Amirhossein Sahebkar; Teresa Cosentino; Matteo Pirro
Journal:  Curr Cardiol Rep       Date:  2018-05-25       Impact factor: 2.931

6.  Legume Consumption and Cardiometabolic Health.

Authors:  Nerea Becerra-Tomás; Christopher Papandreou; Jordi Salas-Salvadó
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

Review 7.  Effects of soy intake on circulating levels of TNF-α and interleukin-6: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Mahdieh Khodarahmi; Elaheh Foroumandi; Mohammad Asghari Jafarabadi
Journal:  Eur J Nutr       Date:  2021-01-05       Impact factor: 5.614

Review 8.  Potential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review.

Authors:  Arrigo F G Cicero; Federica Fogacci; Alessandro Colletti
Journal:  Br J Pharmacol       Date:  2016-09-29       Impact factor: 8.739

9.  Consumption of soy products and cardiovascular mortality in people with and without cardiovascular disease: a prospective cohort study of 0.5 million individuals.

Authors:  Xiaowen Wang; Canqing Yu; Jun Lv; Liming Li; Yonghua Hu; Keyang Liu; Kokoro Shirai; Hiroyasu Iso; Jia-Yi Dong
Journal:  Eur J Nutr       Date:  2021-06-02       Impact factor: 5.614

10.  Effects of isoflavone-containing soya protein on ex vivo cholesterol efflux, vascular function and blood markers of CVD risk in adults with moderately elevated blood pressure: a dose-response randomised controlled trial.

Authors:  Chesney K Richter; Ann C Skulas-Ray; Jennifer A Fleming; Christina J Link; Ratna Mukherjea; Elaine S Krul; Penny M Kris-Etherton
Journal:  Br J Nutr       Date:  2017-05       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.